China Isotope & Radiation Corp. (HK:1763) has released an update.
China Isotope & Radiation Corporation (CIRC) has announced the addition of two new national-level specialized ‘Little Giant’ enterprises, highlighting the company’s progress and strategic development during the ’14th Five-Year Plan’ period. The subsidiaries Shenzhen Zhonghe Headway Bio-Sci & Tech Co., Ltd. and Chengdu Gaotong Isotope Co., Ltd. have been recognized for their specialized and innovative business models, contributing to CIRC’s portfolio of 18 such enterprises. This move signals CIRC’s commitment to high-quality development and value creation for shareholders and potential investors in the evolving industry landscape.
For further insights into HK:1763 stock, check out TipRanks’ Stock Analysis page.
